Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 24 04:00PM ET
19.21
Dollar change
-0.05
Percentage change
-0.26
%
IndexRUT P/E- EPS (ttm)-0.97 Insider Own17.78% Shs Outstand138.39M Perf Week-6.34%
Market Cap2.74B Forward P/E- EPS next Y-2.73 Insider Trans-0.76% Shs Float117.26M Perf Month28.41%
Income-137.25M PEG- EPS next Q-0.67 Inst Own82.11% Short Float8.95% Perf Quarter13.74%
Sales295.39M P/S9.27 EPS this Y-164.73% Inst Trans-0.74% Short Ratio8.85 Perf Half Y6.13%
Book/sh10.21 P/B1.88 EPS next Y2.83% ROA-9.18% Short Interest10.50M Perf Year-38.82%
Cash/sh6.57 P/C2.92 EPS next 5Y- ROE-11.33% 52W Range14.56 - 33.31 Perf YTD-10.48%
Dividend Est.- P/FCF- EPS past 5Y-21.99% ROI-9.16% 52W High-42.33% Beta1.37
Dividend TTM- Quick Ratio11.79 Sales past 5Y264.19% Gross Margin97.32% 52W Low31.94% ATR (14)0.93
Dividend Ex-Date- Current Ratio11.79 EPS Y/Y TTM67.52% Oper. Margin-70.46% RSI (14)53.67 Volatility4.06% 5.19%
Employees445 Debt/Eq0.03 Sales Y/Y TTM191.13% Profit Margin-46.46% Recom1.24 Target Price38.67
Option/ShortYes / Yes LT Debt/Eq0.03 EPS Q/Q15.26% Payout- Rel Volume0.69 Prev Close19.26
Sales Surprise-100.00% EPS Surprise2.14% Sales Q/Q-100.00% EarningsMay 07 AMC Avg Volume1.19M Price19.21
SMA204.82% SMA503.36% SMA200-2.85% Trades Volume813,112 Change-0.26%
Date Action Analyst Rating Change Price Target Change
Dec-13-23Initiated Citigroup Buy $32
Nov-20-23Resumed JP Morgan Overweight $28
Oct-24-23Resumed Cantor Fitzgerald Overweight $85 → $35
Sep-06-23Initiated B. Riley Securities Buy $38
Jan-30-23Initiated SVB Securities Outperform $50
Dec-05-22Initiated Cowen Outperform
Nov-02-22Upgrade BTIG Research Neutral → Buy $38
Nov-02-22Initiated BofA Securities Buy $40
Jun-23-22Initiated Berenberg Buy $39
Dec-10-21Resumed Raymond James Mkt Perform
May-09-24 07:00AM
May-08-24 11:17AM
09:16AM
08:20AM
May-07-24 10:56PM
05:56PM Loading…
05:56PM
04:01PM
May-01-24 08:00AM
Apr-09-24 08:46AM
Apr-08-24 08:00AM
Mar-28-24 11:30AM
Mar-19-24 08:30AM
Feb-28-24 08:08AM
Feb-27-24 08:31AM
08:05AM
08:00AM Loading…
08:00AM
06:53AM
Feb-16-24 08:39AM
08:22AM
07:13AM
Feb-07-24 08:00AM
Feb-01-24 08:00AM
Jan-31-24 11:04PM
Jan-26-24 10:00AM
Jan-11-24 01:11PM
Jan-09-24 08:44AM
Jan-08-24 08:00AM
06:30AM
06:30AM
Jan-02-24 01:57PM
06:22AM Loading…
Dec-22-23 06:22AM
Dec-21-23 09:55AM
Dec-07-23 11:31AM
Nov-27-23 07:01PM
09:55AM
Nov-21-23 06:00AM
Nov-07-23 05:50PM
04:01PM
Nov-06-23 09:55AM
Nov-01-23 10:30AM
Oct-19-23 10:30AM
Oct-06-23 04:41AM
Oct-02-23 07:00AM
Sep-27-23 08:31AM
Sep-11-23 06:30AM
Sep-09-23 03:59PM
Sep-07-23 11:30AM
Aug-30-23 08:30AM
Aug-29-23 09:00AM
Aug-11-23 11:36AM
Aug-10-23 12:02PM
06:03AM
Aug-08-23 06:05PM
04:01PM
Jun-29-23 05:13AM
Jun-27-23 02:23PM
Jun-26-23 10:00AM
Jun-21-23 03:21PM
06:00AM
Jun-20-23 04:20PM
07:00AM
Jun-09-23 11:30AM
Jun-08-23 11:30AM
Jun-07-23 11:30AM
Jun-05-23 06:15PM
May-31-23 01:30PM
May-16-23 06:00AM
May-15-23 04:31PM
May-09-23 01:24PM
May-08-23 05:15PM
04:01PM
May-04-23 01:21PM
May-01-23 10:00AM
Apr-27-23 10:02AM
Apr-14-23 07:03AM
Apr-12-23 08:00AM
Apr-10-23 08:00AM
Apr-04-23 05:12AM
Mar-29-23 11:30AM
Mar-04-23 07:35AM
Feb-28-23 09:01AM
Feb-27-23 05:35PM
04:01PM
Feb-23-23 11:15AM
Feb-22-23 04:33PM
Feb-21-23 10:00AM
Feb-20-23 10:00AM
Feb-15-23 04:01PM
Feb-03-23 01:22PM
Jan-25-23 08:00AM
Jan-09-23 08:00AM
Jan-02-23 06:56AM
Dec-13-22 08:15AM
Dec-06-22 06:35AM
Dec-05-22 07:00AM
Nov-09-22 05:32AM
Nov-04-22 11:52AM
06:23AM
Nov-03-22 05:55PM
04:01PM
Denali Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates for neurodegenerative diseases. Its product pipeline includes LRRK2, RIPK1, TREM2, and Tau. The company was founded by Ryan J. Watts, Marc Tessier-Lavigne, and Alexander Schuth on October 14, 2013 and is headquartered in San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SATO VICKI LDirectorMay 15 '24Sale20.391,67434,133116,369May 17 04:28 PM
SATO VICKI LDirectorApr 15 '24Sale18.291,66630,471118,043Apr 17 05:14 PM
Krognes Steve E.DirectorApr 01 '24Sale20.5092,5001,896,25047,341Apr 02 06:07 PM
SATO VICKI LDirectorMar 15 '24Sale20.101,66633,487119,709Mar 19 04:27 PM
SATO VICKI LDirectorFeb 15 '24Sale18.371,66630,604121,375Feb 20 05:38 PM
Schuth Alexander O.COFO and SecretaryFeb 14 '24Sale17.6620,128355,460187,341Feb 15 09:14 PM
Ho CaroleChief Medical OfficerFeb 14 '24Sale17.791,40524,995143,605Feb 15 09:14 PM
Watts Ryan J.President and CEOFeb 13 '24Sale17.299,589165,794238,067Feb 15 09:15 PM
Ho CaroleChief Medical OfficerFeb 13 '24Sale17.292,78448,135145,010Feb 15 09:14 PM
Krognes Steve E.DirectorFeb 13 '24Sale17.292,75047,548139,841Feb 15 09:16 PM
Schuth Alexander O.COFO and SecretaryFeb 13 '24Sale17.292,71646,960207,469Feb 15 09:14 PM
Schuth Alexander O.COFO and SecretaryFeb 08 '24Option Exercise0.6850,00034,000210,185Feb 12 04:48 PM
SATO VICKI LDirectorJan 16 '24Sale18.421,66630,688123,041Jan 18 06:26 PM
Ho CaroleChief Medical OfficerJan 10 '24Sale19.024,66888,785147,794Jan 12 08:18 PM
Watts Ryan J.President and CEOJan 09 '24Sale19.787,818154,6402,268,363Jan 11 05:28 PM
Watts Ryan J.President and CEOJan 05 '24Sale19.4317,483339,6952,276,181Jan 09 07:33 PM
Ho CaroleChief Medical OfficerJan 05 '24Sale19.439,972193,756198,777Jan 09 07:35 PM
Schuth Alexander O.COFO and SecretaryJan 05 '24Sale19.439,972193,756539,307Jan 09 07:34 PM
Krognes Steve E.DirectorJan 05 '24Sale19.433,20862,331142,591Jan 09 07:34 PM
SATO VICKI LDirectorDec 15 '23Sale23.391,66638,968124,707Dec 18 07:30 PM
SATO VICKI LDirectorNov 15 '23Sale19.131,66631,871126,373Nov 16 06:14 PM
SATO VICKI LDirectorOct 16 '23Sale20.661,66634,420128,039Oct 18 04:44 PM
SATO VICKI LDirectorSep 15 '23Sale23.621,66639,348129,705Sep 19 04:45 PM
Ho CaroleChief Medical OfficerAug 23 '23Sale23.222,52258,561182,809Aug 25 05:30 PM
Schuth Alexander O.COFO and SecretaryAug 23 '23Sale23.172,52258,435518,989Aug 25 05:36 PM
Ho CaroleChief Medical OfficerAug 21 '23Sale22.602,47856,003185,331Aug 23 04:34 PM
Schuth Alexander O.COFO and SecretaryAug 21 '23Sale22.592,47855,978521,511Aug 23 04:33 PM
Watts Ryan J.President and CEOAug 21 '23Sale22.592,30952,1602,242,604Aug 23 04:32 PM
Krognes Steve E.DirectorAug 21 '23Sale22.601,41932,069145,799Aug 23 04:31 PM
SATO VICKI LDirectorAug 15 '23Sale24.301,66640,484131,371Aug 17 06:42 PM
Ho CaroleChief Medical OfficerAug 14 '23Sale23.792,76865,851182,809Aug 16 06:20 PM
Schuth Alexander O.COFO and SecretaryAug 14 '23Sale23.672,77265,613518,989Aug 16 06:19 PM
Watts Ryan J.President and CEOAug 10 '23Option Exercise0.682,5261,7182,242,439Aug 14 05:13 PM
Ho CaroleChief Medical OfficerAug 10 '23Sale24.152,85768,997185,577Aug 14 05:12 PM
Schuth Alexander O.COFO and SecretaryAug 10 '23Sale24.182,85368,986521,761Aug 14 05:11 PM
Watts Ryan J.President and CEOAug 10 '23Sale25.032,52663,2262,239,913Aug 14 05:13 PM
Schuth Alexander O.COFO and SecretaryJul 18 '23Sale30.019,702291,157518,989Jul 19 05:10 PM
Schuth Alexander O.COFO and SecretaryJul 17 '23Option Exercise5.2810,00052,800538,691Jul 19 05:10 PM
Schuth Alexander O.COFO and SecretaryJul 17 '23Sale29.6010,000296,000528,691Jul 19 05:10 PM
SATO VICKI LDirectorJul 17 '23Sale29.601,66649,314133,037Jul 19 05:09 PM
SATO VICKI LDirectorJun 28 '23Sale29.841,66649,709134,703Jun 30 05:21 PM